Sanofi
Our Company
Our Company
Our Strategy
Governance
Governance
Board of Directors
Executive Committee
Specialist Committees
Sustainability
Sustainability
Sustainable and Equitable Access to Healthcare
Environmental Impact and Healthcare Systems’ Resilience
Code of Conduct and Responsible Business
Diversity, Equity, and Inclusion In and Beyond the Workplace
Global Health Unit
Our Legacy
Our Science
Our Science
Our Pipeline
Our R&D Focus
Our R&D Focus
Immunology R&D
Neurology R&D
Oncology R&D
Rare Blood Disorders R&D
Rare Diseases R&D
Vaccines R&D
Artificial Intelligence in R&D
Technology Platforms
Clinical Trials & Results
Clinical Trials & Results
Find a Clinical Trial
Clinical Study Results
Investigator Sponsored Studies
Diversity in Clinical Trials
Scientific Collaboration
Scientific Collaboration
External Innovation in North America
External Innovation in Europe
Scientific Collaboration in China
Digital & AI
Manufacturing and Supply
Manufacturing and Supply
Vaccines Manufacturing and Supply
Your Health
Your Health
Vaccines & Infectious Diseases
Vaccines & Infectious Diseases
Influenza
Meningococcal Meningitis
Pertussis
Respiratory Syncytial Virus (RSV)
Why Vaccines Matter
Medicines
Medicines
Immunology
Neurology
Oncology
Rare Blood Disorders
Rare Diseases
Cardiovascular Diseases
Diabetes
Patient Engagement
Healthcare Professionals Support
Healthcare Professionals Support
Managed Access Programs (MAPs)
Pre-Registration Import Licenses
Post Trial Access (PTA)
Consumer Healthcare (Opella)
Partnering
Partnering
Partnering Focus Areas
Partnering Focus Areas
China
Digital
General Medicines
Immunology
Neuroscience
Oncology
Out-Licensing
Rare Disease
Technology Platforms
Vaccines
Meet the Partnering Team
Contact Business Development Team
Media
Media
Stories
Press Releases
Contacts
Investors
Investors
News and Events
News and Events
News
Upcoming Events
Past Events
Shares, ADRs and Bonds
Shares, ADRs and Bonds
Share Price
Dividend
Shares, Structure and Vote
Bonds
Analyst Coverage and Vara Consensus
Share Repurchases
American Depositary Receipts
Financial Reports and Other Publications
Environment, Social, Governance
Private Shareholders
Contacts and Subscription
Careers
Global
Homepage
Investors
Shares, ADRs and Bonds
Share Repurchases
Share Repurchases
Description of share repurchase programs
Annual Report - Registration document 2024 : “Programme de rachat d’actions” (Share repurchase programs) (in French)
Annual Report - Registration document 2023 : “Programme de rachat d’actions” (Share repurchase programs) (in French)
Annual Report - Registration document 2022 : “Programme de rachat d’actions” (Share repurchase programs) (in French)
Annual Report - Registration document 2021: “Programme de rachat d’actions” (Share repurchase programs) (in French)
Annual Report - Registration document 2020: “Programme de rachat d’actions” (Share repurchase programs) (in French)
Disclosures of trading in own shares
Share repurchases in 2025
July 2025
Disclosure of trading in own shares in July 2025
Disclosure of trading in own shares from July 28, 2025 to August 01, 2025
Disclosure of trading in own shares from July 21, 2025 to July 25, 2025
Disclosure of trading in own shares from July 14, 2025 to July 18, 2025
Disclosure of trading in own shares from July 07, 2025 to July 11, 2025
Disclosure of trading in own shares from June 30, 2025 to July 04, 2025
June 2025
Disclosure of trading in own shares in June 2025
Disclosure of trading in own shares from June 23, 2025 to June 27, 2025
Disclosure of trading in own shares from June 16, 2025 to June 20, 2025
Disclosure of trading in own shares from June 09, 2025 to June 13, 2025
Disclosure of trading in own shares from June 02, 2025 to June 06, 2025
May 2025
Disclosure of trading in own shares in May 2025
Disclosure of trading in own shares from May 05, 2025 to May 09, 2025
April 2025
Disclosure of trading in own shares in April 2025
Disclosure of trading in own shares from April 28, 2025 to May 02, 2025
Disclosure of trading in own shares from April 21, 2025 to April 25, 2025
Disclosure of trading in own shares from April 14, 2025 to April 17, 2025
Disclosure of trading in own shares from April 07, 2025 to April 11, 2025
Disclosure of trading in own shares from March 31, 2025 to April 04, 2025
March 2025
Disclosure of trading in own shares in March 2025
Disclosure of trading in own shares from March 24, 2025 to March 28, 2025
Disclosure of trading in own shares from March 17, 2025 to March 21, 2025
Disclosure of trading in own shares from March 10, 2025 to March 14, 2025
Disclosure of trading in own shares from March 03, 2025 to March 07, 2025
February 2025
Disclosure of trading in own shares in February 2025
Disclosure of trading in own shares from February 03, 2025 to February 07, 2025
Disclosure of trading in own shares from February 10, 2025 to February 14, 2025
Disclosure of trading in own shares from February 17, 2025 to February 21, 2025
Disclosure of trading in own shares from February 24, 2025 to February 28, 2025
All archives
Quick links
About Sanofi
Financial Result and Investor Events
Shares and ADRs
Shareholder publications
Shareholder tools
Stock chart
Shareholder publications
Share Repurchases (Archives)